Surekha Koppala

Surekha Koppala

Active Director Director DIN 08334006
DIN 08334006 First appointment Jan 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2019
Shareholding value •••• Premium profile

About Surekha Koppala

Data last updated:

Surekha Koppala is a Director at Irads Vascular Clinic Private Limited (since 2019). The company operates in Healthcare. Irads Vascular Clinic Private Limited reported revenue of ₹3.22 Cr (FY 2025).

DIN 08334006
Primary Designation Director
Industry Healthcare
First Appointment 16 Jan 2019
Oldest Company Age 7 yrs
Largest company Irads Vascular Clinic Private Limited · ₹3.22 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jan 20192019₹3.22 Cr (FY 2025)Active

Board colleagues of Surekha Koppala

Directorship timeline

Open interactive timeline →
Irads Vascular Clinic Private Limited
Premium access

Shareholding and investment profile for Surekha Koppala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surekha Koppala

Surekha Koppala currently holds 1 directorship: Irads Vascular Clinic Private Limited (Director, since 16 Jan 2019, revenue ₹3.22 Cr (FY 2025)).

Surekha Koppala was first appointed on 16 Jan 2019 as Director at Irads Vascular Clinic Private Limited.

The current boards of Surekha Koppala's companies include Rajah Vikramaditya Koppala (Irads Vascular Clinic Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available